Sign up USA
Proactive Investors - Run By Investors For Investors

Medtronic recalls diabetes infusion sets on concerns of over-delivery of insulin risk

"Our Medtronic Diabetes team will work as quickly as possible to complete all exchanges to the new and enhanced set and fully support our customers throughout this process," said Francine Kaufman
Medtronic
Medtronic is the world’s largest manufacturer of pacemakers and defibrillators

Medtronic Inc (NYSE:MDT) has issued a voluntary recall of its diabetes infusion sets that are used with all models of its insulin pumps.

The recall comes after reports from patients that a discontinued component, the vent membrane, may be susceptible to being blocked by fluid during priming and fill-tubing.

The company said this can lead to over-delivery of insulin shortly after an infusion set change, which can lead to hypoglycemia.

READ: Medtronic skips lower as IT disruption hampers first quarter sales

Medtronic has recommended that customers use only infusion sets made with the new and enhanced membrane.

"Our Medtronic Diabetes team will work as quickly as possible to complete all exchanges to the new and enhanced set and fully support our customers throughout this process," said Francine Kaufman, chief medical officer of Medtronic's diabetes group.

View full MDT profile View Profile

Medtronic Timeline

Related Articles

Cells
May 17 2017
Revenues are on the rise and the group’s efforts to bring in new business is delivering.
diagram of the human microbiome
September 13 2017
OptiBiotix is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin
cancer cells under a microscope
June 26 2017
The first system LIGHT system will be installed in its Harley Street facility, which is scheduled to be ready for installation by the first half of 2019
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use